Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines
Matthew Kennedy-Martin(Kennedy Martin Health Outcomes (United Kingdom)), Kristina S. Boye(Eli Lilly (United States)), Jan J.V. Busschbach(Erasmus University Rotterdam), Mandy van Reenen(EuroQol Research Foundation), Tessa Kennedy‐Martin(Kennedy Martin Health Outcomes (United Kingdom)), Bernhard Slaap(Erasmus MC), Michael Herdman(Office Of Health Economics), Wolfgang Greiner(Bielefeld University)
Cited by 310
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results
|Trials|2015|863
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
|Quality of Life Research|2010|476